Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Structural biology of SARS-CoV-2 and implications for therapeutic development

Structural biology of SARS-CoV-2 and implications for therapeutic development The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an unprecedented global health crisis. However, therapeutic options for treatment are still very limited. The development of drugs that target vital proteins in the viral life cycle is a feasible approach for treating COVID-19. Belonging to the subfamily Orthocoronavirinae with the largest RNA genome, SARS-CoV-2 encodes a total of 29 proteins. These non-structural, structural and accessory proteins participate in entry into host cells, genome replication and transcription, and viral assembly and release. SARS-CoV-2 proteins can individually perform essential physiological roles, be components of the viral replication machinery or interact with numerous host cellular factors. In this Review, we delineate the structural features of SARS-CoV-2 from the whole viral particle to the individual viral proteins and discuss their functions as well as their potential as targets for therapeutic interventions. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Reviews Microbiology Springer Journals

Structural biology of SARS-CoV-2 and implications for therapeutic development

Nature Reviews Microbiology , Volume 19 (11) – Nov 1, 2021

Loading next page...
 
/lp/springer-journals/structural-biology-of-sars-cov-2-and-implications-for-therapeutic-kl3OWRnHEI

References (160)

Publisher
Springer Journals
Copyright
Copyright © Springer Nature Limited 2021
ISSN
1740-1526
eISSN
1740-1534
DOI
10.1038/s41579-021-00630-8
Publisher site
See Article on Publisher Site

Abstract

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an unprecedented global health crisis. However, therapeutic options for treatment are still very limited. The development of drugs that target vital proteins in the viral life cycle is a feasible approach for treating COVID-19. Belonging to the subfamily Orthocoronavirinae with the largest RNA genome, SARS-CoV-2 encodes a total of 29 proteins. These non-structural, structural and accessory proteins participate in entry into host cells, genome replication and transcription, and viral assembly and release. SARS-CoV-2 proteins can individually perform essential physiological roles, be components of the viral replication machinery or interact with numerous host cellular factors. In this Review, we delineate the structural features of SARS-CoV-2 from the whole viral particle to the individual viral proteins and discuss their functions as well as their potential as targets for therapeutic interventions.

Journal

Nature Reviews MicrobiologySpringer Journals

Published: Nov 1, 2021

There are no references for this article.